fromNature1 month agoMedicineAlzheimer's Drugs Are Finally Tackling the Disease Itself. Here's HowAmyloid-targeting therapies modestly slow Alzheimer's, yet long preclinical phases, variable progression, and unclear causes mean major questions and substantial work remain.
fromwww.scientificamerican.com1 month agoMedicineSee How Alzheimer's Disease WorksAnd How the Newest Treatments Fight ItFDA-approved amyloid-clearing therapies modestly slow Alzheimer's cognitive decline, yet disease biology remains complex with long preclinical phases and many unresolved questions.
fromwww.scientificamerican.com1 month agoMedicineSee How Alzheimer's Disease WorksAnd How the Newest Treatments Fight It
